Retapamulin
Retapamulin
Retapamulin (pronounced reh-tuh-pam-yoo-lin) is a topical antibiotic used in the treatment of skin infections. It is a member of the pleuromutilin class of antibiotics and is primarily used to treat impetigo, a common bacterial skin infection.
Etymology
The name "Retapamulin" is derived from the class of antibiotics it belongs to, pleuromutilin, and its chemical structure. The "Ret" prefix is a reference to its reticulated structure, while "apamulin" is a combination of "pleuromutilin" and "pam", a common suffix in drug nomenclature.
Usage
Retapamulin is used topically, meaning it is applied directly to the skin. It is primarily used to treat impetigo, a skin infection caused by the Staphylococcus aureus or Streptococcus pyogenes bacteria. It may also be used to treat other skin infections as determined by a healthcare provider.
Mechanism of Action
Retapamulin works by inhibiting the synthesis of bacterial proteins, which are necessary for the bacteria to grow and multiply. It does this by binding to the 50S subunit of the bacterial ribosome, preventing the formation of new proteins.
Side Effects
Common side effects of Retapamulin include irritation at the site of application, itching, and redness. More serious side effects can include allergic reactions, such as hives, difficulty breathing, and swelling of the face, lips, tongue, or throat.
Related Terms
External links
- Medical encyclopedia article on Retapamulin
- Wikipedia's article - Retapamulin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski